Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-004610
Filing Date
2025-04-08
Accepted
2025-04-08 17:15:26
Documents
22
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A capr-20250522xdef14a.htm   iXBRL DEF 14A 1064004
2 GRAPHIC capr-20250522xdef14a_a002.jpg GRAPHIC 8333
3 GRAPHIC capr-20250522xdef14a_a003.jpg GRAPHIC 5528
4 GRAPHIC capr-20250522xdef14a_a010.jpg GRAPHIC 35756
5 GRAPHIC capr-20250522xdef14a_a011.jpg GRAPHIC 35437
6 GRAPHIC capr-20250522xdef14a_bg001.jpg GRAPHIC 86103
7 GRAPHIC capr-20250522xdef14a_bg002.jpg GRAPHIC 160100
  Complete submission text file 0001558370-25-004610.txt   2873607

Data Files

Seq Description Document Type Size
8 EX-101.SCH capr-20250522.xsd EX-101.SCH 3997
9 EX-101.DEF capr-20250522_def.xml EX-101.DEF 1966
10 EX-101.LAB capr-20250522_lab.xml EX-101.LAB 3683
11 EX-101.PRE capr-20250522_pre.xml EX-101.PRE 3919
24 EXTRACTED XBRL INSTANCE DOCUMENT capr-20250522xdef14a_htm.xml XML 344695
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34058 | Film No.: 25822859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)